Power and sample size calculations for the Wilcoxon-Mann-Whitney test in the presence of death-censored observations

The Balanced Survivor Average Causal Effect

(2013) Tom Greene et al.  

The Combined Assessment of Function and Survival (CAFS): A new endpoint for ALS clinical trials

(2013) James D. Berry et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia

(2012) Sumeet Subherwal et al.   AMERICAN HEART JOURNAL

End Points for Comparative Effectiveness Research in Heart Failure

(2012) Larry A. Allen et al.   Heart Failure Clinics

Combining Censored and Uncensored Data in a U-Statistic: Design and Sample Size Implications for Cell Therapy Research

(2011) Lemuel A Moyé et al.  

Power and Sample Size Estimation for the Clustered Wilcoxon Test

(2010) Bernard Rosner et al.   BIOMETRICS

End Points for Clinical Trials in Acute Heart Failure Syndromes

(2009) Larry A. Allen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Medical complications after stroke

(2009) Sandeep Kumar et al.   LANCET NEUROLOGY

Sample Size Determinations for the Wilcoxon–Mann–Whitney Test: A Comprehensive Review

(2009) Dewi Rahardja et al.   Statistics in Biopharmaceutical Research

Power and Sample Size Estimation for the Wilcoxon Rank Sum Test with Application to Comparisons of C Statistics from Alternative Prediction Models

(2008) B. Rosner et al.   BIOMETRICS

A Global Ranking Approach to End Points in Trials of Mechanical Circulatory Support Devices

(2008) G. Michael Felker et al.   JOURNAL OF CARDIAC FAILURE